Titular de la autorización de comercialización
Bayer Hlthcare
62 medicamentos en 1 país, como titular de la autorización.
Titular de la autorización de comercialización
62 medicamentos en 1 país, como titular de la autorización.
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos registrados a su nombre, primero los vigentes.
1–25 de 62
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ADEMPAS0.5mg | 1.5mg | 1mg | 2.5mg | 2mg · Tablet | Riociguat | Estados Unidos | Comercializado | 2013 |
| ALEVE PM25mg; 220mg · Tablet | Diphenhydramine, Naproxen | Estados Unidos | Comercializado | 2014 |
| ANGELIQ0.25mg; 0.5mg | 0.5mg; 1mg · Tablet | Drospirenona, Estradiol | Estados Unidos | Comercializado | 2005 |
| ANGIOVIST 28260% · Injectable | Diatrizoate | Estados Unidos | No comercializado | 1982 |
| ANGIOVIST 29252%; 8% · Injectable | Diatrizoate | Estados Unidos | No comercializado | 1982 |
| ANGIOVIST 37066%; 10% · Injectable | Diatrizoate | Estados Unidos | No comercializado | 1982 |
| ASTEPRO ALLERGY0.2055mg/spray · Spray, metered | Azelastine | Estados Unidos | Comercializado | 2021 |
| AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Moxifloxacin | Estados Unidos | No comercializado | 2001 |
| BEYAZ3mg,n/a; 0.02mg,n/a; 0.451mg,0.451mg · Tablet | Drospirenona, N/a, Ethinyl estradiol, Levomefolate | Estados Unidos | Comercializado | 2010 |
| BILIVIST500mg · Capsule | Sodium iopodate | Estados Unidos | No comercializado | 1982 |
| BILTRICIDE600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Praziquantel | Estados Unidos | No comercializado | 1982 |
| CHILDREN'S ASTEPRO ALLERGY0.2055mg/spray · Spray, metered | Azelastine | Estados Unidos | Comercializado | 2021 |
| CIPRO1200MG/120ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG/20ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG/40ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or e · Injectable | Ciprofloxacin | Estados Unidos | No comercializado | 1990 |
| CIPRO250mg/5ml | 500mg/5ml · For suspension | Ciprofloxacin | Estados Unidos | Comercializado | 1997 |
| CIPRO250MG BASE | 500MG BASE | 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ciprofloxacin | Estados Unidos | Comercializado | 1987 |
| CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Ciprofloxacin | Estados Unidos | No comercializado | 1990 |
| CIPRO XR212.6MG; 287.5MG BASE | 212.6MG; 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 425.2MG; 574.9MG BASE | 425.2MG; 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Ciprofloxacin | Estados Unidos | Comercializado | 2002 |
| CLIMARA0.025mg/24hr | 0.0375mg/24hr | 0.05mg/24hr | 0.06mg/24hr | 0.075mg/24hr | 0.1mg/24hr · Film, extended release | Estradiol | Estados Unidos | Comercializado | 1994 |
| CLIMARA PRO0.045mg/24hr; 0.015mg/24hr · Film, extended release | Estradiol, Levonorgestrel | Estados Unidos | Comercializado | 2003 |
| DTIC-DOME100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Dacarbazine | Estados Unidos | No comercializado | 1975 |
| EOVIST1.8143gm/10ml (181.43mg/ml) | 2.72145gm/15ml (181.43mg/ml) · Solution | Gadoxetic acid | Estados Unidos | Comercializado | 2008 |
| GADAVIST1.20944gm/2ml (604.72mg/ml) | 18.1416gm/30ml (604.72mg/ml) | 39.3068gm/65ml (604.72mg/ml) | 4.5354gm/7.5ml (604.72mg/ml) | 6.0472gm/10ml (604.72mg/ml) | 9.0708gm/15ml (604.72mg/ml) · Solution | Gadobutrol | Estados Unidos | Comercializado | 2011 |
| GASTROVIST66%; 10% · Solution | Diatrizoate | Estados Unidos | No comercializado | 1982 |
| KERENDIA10mg | 20mg | 40mg · Tablet | Finerenone | Estados Unidos | Comercializado | 2021 |
| KYLEENA19.5mg · System | Levonorgestrel | Estados Unidos | Comercializado | 2016 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Estados Unidos | 62 | 62 | 0 | EmpresasTodos los medicamentos |
Los principios activos presentes en la mayoría de sus medicamentos.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Bayer Hlthcare en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaOtras empresas del mismo grupo.